Attributable Risk and Economic Cost of Cardiovascular Hospital Admissions Due to Ambient Particulate Matter in Wuhan, China

Int J Environ Res Public Health. 2020 Jul 29;17(15):5453. doi: 10.3390/ijerph17155453.

Abstract

Although the adverse effects of ambient particulate matter (PM) on cardiovascular disease (CVD) have been previously documented, information about their economic consequence was insufficient. This study aimed to evaluate the attributable risk and economic cost of cardiovascular hospitalizations due to ambient PM. Data of CVD hospitalizations and PM concentrations from 1 January 2015 to 31 December 2017 were collected in Wuhan, China. A generalized additive model was applied to quantify the PM-attributable CVD hospitalizations, and total attributable hospitalization costs were calculated via multiplying the total attributable cases by the case-average hospitalization costs. A total of 45,714 CVD hospitalizations were included in this study. The results showed that a 10 µg/m3 increase in PM2.5 and PM10 concentrations at lag7 day, respectively, contributed to a 1.01% (95% confidence interval: 0.67-1.34) and 0.48% (0.26-0.70) increase in CVD hospitalizations. During the study period, 1487 and 983 CVD hospitalizations were attributable to PM2.5 and PM10, equaling an economic cost of 29.27 and 19.34 million RMB (1 RMB = 0.1424 USD), respectively, and significant differences in PM-attributable hospitalizations and economic burden were found between gender and age groups. Our study added evidence in heavily polluted megacities regarding the increased health risk and economic cost of CVD hospitalizations associated with ambient particulate pollution.

Keywords: ambient particulate matter; attributable hospitalization costs; cardiovascular disease; hospitalizations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Air Pollutants / adverse effects
  • Air Pollutants / analysis
  • Air Pollution / adverse effects
  • Air Pollution / analysis
  • Air Pollution / statistics & numerical data*
  • Cardiovascular Diseases / economics
  • Cardiovascular Diseases / epidemiology*
  • China / epidemiology
  • Hospitalization / economics*
  • Hospitalization / statistics & numerical data
  • Humans
  • Particulate Matter / adverse effects
  • Particulate Matter / analysis*

Substances

  • Air Pollutants
  • Particulate Matter